Loading company financials…
NASDAQ NMS - GLOBAL MARKET · Financial Services · CIK 0001156375
$305.98
+3.45% · delayed ~15 min
Last price from Oct 22, 2026
$110.05B market value
From CME GROUP INC.'s FY2025 10-K, filed Feb 26, 2026 · read the filing
CME trades securities and runs financial markets. It took in $6.52B last year, which makes it a mid-sized company. Of every dollar it sells, about 62 cents is left as profit.
The financial picture is led by profitability, with growth and debt worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by GEPSMAN MARTIN J, not under a pre-arranged plan.
$121.0K sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
Generally healthy, with a few things to watch.
From CME GROUP INC.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Cash
$2.89B → $4.42B
Profit
$3.53B → $4.07B
Profit margin
57.5% → 62.5%
Free cash flow
$3.60B → $4.19B
Measured against FY2024, from the 10-K filed Feb 26, 2026
Improved: +52.7%
$2.89B to $4.42BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +15.5%
$3.53B to $4.07BSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote delayed ~15 min), and what was published around it
CME rose 3.45% on the latest quote. The average Financials company tracked here moved +1.08%, and the S&P 500 −1.04%. That is 2.4 points above its sector and 4.5 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 21 analysts covering this company, as of . Their views, not this site's.
Of 21 analysts publishing on this company, 2 say strong buy, 9 say buy, 7 say hold and 3 say sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 62 cents of every dollar of sales as profit, earning $4.07B last year.
Slowly. Sales grew 6.4% last year.
For every $1 it owes, it owns $1.17 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 97 cents of every dollar of profit, which leaves little room for the payment to survive a bad year. It paid out 92% of the cash its operations generated. It has paid in each of the last 12 years.
MixedFigures from the FY2025 annual filing
Last year it earned $4.07B and generated $4.28B of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 26, 2026Filing for FY2025 | FY202410-K · Feb 27, 2025Filing for FY2024 | FY202310-K · Feb 26, 2026Filing for FY2023 | FY202210-K · Feb 27, 2023Filing for FY2022 | FY202110-K · Feb 26, 2026Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $6.52B | $6.13B | $5.58B | $5.02B | $4.69B | +6.4% |
| Operating income | $4.23B | $3.93B | $3.44B | $3.02B | $2.65B | +7.6% |
| Operating marginOperating income ÷ revenueWhat is this? | 64.9% | 64.1% | 61.6% | 60.1% | 56.4% | +0.7 pts |
| Interest expense | $173.4M | $160.9M | $159.4M | $162.7M | $166.9M | +7.8% |
| Income before tax | $5.33B | $4.54B | $4.15B | $3.49B | $3.37B | +17.4% |
| Net income | $4.07B | $3.53B | $3.23B | $2.69B | $2.64B | +15.5% |
| Net marginNet income ÷ revenueWhat is this? | 62.5% | 57.5% | 57.8% | 53.6% | 56.2% | +4.9 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $11.32 | $9.81 | $8.99 | $7.50 | $7.36 | +15.4% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| CMECME GROUP INC. · this page | 7.3/10 | 6/7 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Sold on the open market — 400 shares at $302.50 ($121.0K)
Holds 25,244 shares after this filing.
Reported another kind of transaction — 2,554 shares
Holds 1,067 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Published results
Read the filingAmended its charter or changed its financial year
Read the filingWrite down why you are following CME GROUP INC., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 51 subsidiaries named in its 10-K, incorporated across 17 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from CME's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 26, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 7 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 7.3 | 6/7 | 10-K, filed Feb 26, 2026 |
| FY2024 | 7.3 | 6/7 | 10-K, filed Feb 27, 2025 |
| FY2023 | 7.3 | 7/7 | 10-K, filed Feb 28, 2024 |
| FY2022 | 7.3 | 7/7 | 10-K, filed Feb 27, 2023 |
| FY2021 | 6.0 | 4/7 | 10-K, filed Feb 25, 2022 |
| FY2020 | 7.3 | 4/7 | 10-K, filed Feb 26, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
6 of 7 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 2 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +4.9 pts
57.5% to 62.5%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +16.6%
$3.60B to $4.19BSignificant
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Improved: +15.4%
$9.81 to $11.32Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +6.4%
$6.13B to $6.52BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +7.6%
$3.93B to $4.23BNotable
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Changed: +9.7%
$3.58B to $3.93BNotable
Why it matters: Cash handed to shareholders. A rise can be a higher dividend or simply more shares, and a cut is a decision the company explains in its own filing — neither is rated here.
Changed: -11.2%
$94.0M to $83.5MNotable
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Jul 24, 2026 — read it.
Deteriorated: −1.9 pts
66.7% to 64.9%Notable
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Improved: +8.2%
$1.98B to $2.14BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Jul 24, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Deteriorated: -15.5%
$1.31B to $1.11BSignificant
Why it matters: Profit from running the business, before interest and tax. Less exposed than profit to one-off financing and tax items, so a clearer read on the business itself.
Deteriorated: −4.8 pts
69.7% to 64.9%Significant
Why it matters: What survives each sale after running the business. A falling operating margin beside a steady gross margin points at overheads — wages, marketing, research — rather than pricing.
Deteriorated: -9.2%
$1.88B to $1.71BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: -9.7%
$1.15B to $1.04BNotable
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: -10.1%
$3.21 to $2.89Notable
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -10.3%
$2.39B to $2.14BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
2 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 1.5% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 26.7x — investors pay $26.7 for each $1 of trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
| 6.4% |
| 62.5% |
| 27.02x |
| 5.91x |
| SPGIS&P Global Inc. | 9.0/10 | 7/9 | 7.9% | 29.2% | 30.28x | 0.80x |
|---|
| ICEIntercontinental Exchange, Inc. | 7.3/10 | 7/8 | 7.5% | 26.2% | 28.02x | 3.73x |
|---|
| MCOMOODYS CORP /DE/ | 8.7/10 | 8/9 | 8.9% | 31.9% | 35.95x | 2.87x |
|---|
| NDAQNASDAQ, INC. | 7.3/10 | 9/9 | 11.6% | 21.6% | 32.93x | 1.54x |
|---|
| COINCoinbase Global, Inc. | 7.3/10 | 4/8 | 9.4% | 17.6% | 35.93x | 1.01x |
|---|
| MSCIMSCI Inc. | 7.3/10 | 8/9 | 9.7% | 38.4% | 37.95x | -3.15x |
|---|
| CBOECboe Global Markets, Inc. | 8.7/10 | 8/9 | 15.1% | 23.3% | 31.18x | 0.81x |
|---|
| Median of peers | 7.3/10 | — | 9.4% | 26.2% | 32.93x | 1.01x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Reported another kind of transaction — 2,554 shares
Holds 262,996 shares after this filing.
Bought on the open market — 293 shares at $268.76 ($78.6K)
Holds 263,289 shares after this filing.
Was granted or awarded shares — 2,592 shares at $275.09 ($713.0K)
Holds 14,700 shares after this filing.
Had shares withheld to cover taxes — 302 shares at $275.09 ($83.1K)
Holds 14,398 shares after this filing.
Had shares withheld to cover taxes — 330 shares at $275.09 ($90.8K)
Holds 14,068 shares after this filing.
Had shares withheld to cover taxes — 338 shares at $275.09 ($93.0K)
Holds 13,730 shares after this filing.
Had shares withheld to cover taxes — 364 shares at $272.46 ($99.2K)
Holds 13,366 shares after this filing.
Reported another kind of transaction — 4,629 shares
Holds 8,683 shares after this filing.
Reported another kind of transaction — 4,629 shares
Holds 15,657 shares after this filing.
Was granted or awarded shares — 2,864 shares at $275.09 ($787.9K)
Holds 11,547 shares after this filing.
Had shares withheld to cover taxes — 373 shares at $275.09 ($102.6K)
Holds 11,174 shares after this filing.
Had shares withheld to cover taxes — 361 shares at $275.09 ($99.3K)
Holds 10,813 shares after this filing.
Had shares withheld to cover taxes — 320 shares at $275.09 ($88.0K)
Holds 10,493 shares after this filing.
Had shares withheld to cover taxes — 359 shares at $272.46 ($97.8K)
Holds 10,134 shares after this filing.
Was granted or awarded shares — 2,864 shares at $275.09 ($787.9K)
Holds 16,700 shares after this filing.
Had shares withheld to cover taxes — 249 shares at $275.09 ($68.5K)
Holds 16,451 shares after this filing.
Had shares withheld to cover taxes — 275 shares at $275.09 ($75.6K)
Holds 16,176 shares after this filing.
Had shares withheld to cover taxes — 320 shares at $275.09 ($88.0K)
Holds 15,856 shares after this filing.
Had shares withheld to cover taxes — 308 shares at $272.46 ($83.9K)
Holds 15,548 shares after this filing.
Was granted or awarded shares — 700 shares at $275.09 ($192.6K)
Holds 26,109 shares after this filing.
Had shares withheld to cover taxes — 44 shares at $275.09 ($12.1K)
Holds 26,065 shares after this filing.
Had shares withheld to cover taxes — 47 shares at $275.09 ($12.9K)
Holds 26,018 shares after this filing.
Had shares withheld to cover taxes — 205 shares at $275.09 ($56.4K)
Holds 25,813 shares after this filing.
Had shares withheld to cover taxes — 51 shares at $272.46 ($13.9K)
Holds 25,762 shares after this filing.
Was granted or awarded shares — 2,592 shares at $275.09 ($713.0K)
Holds 21,443 shares after this filing.
Had shares withheld to cover taxes — 320 shares at $275.09 ($88.0K)
Holds 21,123 shares after this filing.
Had shares withheld to cover taxes — 309 shares at $275.09 ($85.0K)
Holds 20,814 shares after this filing.
Had shares withheld to cover taxes — 274 shares at $275.09 ($75.4K)
Holds 20,540 shares after this filing.
Had shares withheld to cover taxes — 308 shares at $272.46 ($83.9K)
Holds 20,232 shares after this filing.
Was granted or awarded shares — 2,864 shares at $275.09 ($787.9K)
Holds 32,974 shares after this filing.
Had shares withheld to cover taxes — 373 shares at $275.09 ($102.6K)
Holds 32,601 shares after this filing.
Had shares withheld to cover taxes — 361 shares at $275.09 ($99.3K)
Holds 32,240 shares after this filing.
Had shares withheld to cover taxes — 320 shares at $275.09 ($88.0K)
Holds 31,920 shares after this filing.
Had shares withheld to cover taxes — 359 shares at $272.46 ($97.8K)
Holds 31,561 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 400 shares ($121.0K) on or after .
Shares originally obtained via Restricted Stock.
Filed notice to sell 388 shares ($106.1K) on or after .
Shares originally obtained via Restricted Stock.
Filed notice to sell 500 shares ($140.1K) on or after .
Shares originally obtained via Restricted Stock.
Filed notice to sell 15,000 shares ($4.1M) on or after .
Shares originally obtained via executive compensation grant.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Had a director or senior officer leave or join
Made a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2026
Operating margin −1.9 pts · Cash +8.2% — against Q2 FY2025
Read the filingPublished results
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingHeld a shareholder vote
Read the filingHeld a shareholder vote
Read the filingSigned a material agreement
Read the filingQuarterly report for Q1 FY2026
Revenue +14.5% · Operating margin +2.2 pts · Cash +70.2% — against Q1 FY2025
Read the filingPublished results
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Revenue +6.4% · Profit margin +4.9 pts · Cash +52.7% — against FY2024
Read the filingPublished results
Read the filingMade a Regulation FD disclosure
Read the filingQuarterly report for Q3 FY2025
Operating margin −1.4 pts · Operating income -5.0% · Profit margin +1.4 pts — against Q3 FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join
Read the filingReported another event
Read the filingThe first 40 of 51. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-02-26. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
Can Uniswap (UNI) Get Back to $10 After a 21% Monthly Drop?
Yahoo ·
Financial Exchanges CME, Cboe, ICE, Nasdaq Benefiting From Sector Rotation Out Of AI Stocks
Yahoo ·
CME Group (CME) Stock Climbs On Record Q3 Earnings And Margin Strength
Yahoo ·
How Much Downside Is Left In Coinbase Stock?
Yahoo ·
NDAQ Q3 Earnings Beat Estimates on Index and FinTech Growth
Yahoo ·
What Happens to AI Stocks if the Fed Hikes Rates Again?
Yahoo ·
CME Q3 deep dive: diversified volume growth and product innovation underpin results
Yahoo ·
JP Morgan Upgrades CME Group to Overweight, Announces $367 Price Target
Benzinga ·
Should One Shrinking Number Scare You About Coinbase Stock?
Yahoo ·
CME CEO Says Crypto Perps Are Swaps While Suing CFTC Over Their Approval
Yahoo ·
What Will 100 Hyperliquid (HYPE) Be Worth by 2030?
Yahoo ·
CME Group: 3 Key Takeaways for Long-Term Investors
Yahoo ·
Primary sources and further research